维普中文期刊产品整合服务
34篇 您的检索式:作者名="STOCKIS A"
    题名 作者 年代 出处 被引量
1Nitazoxanide:pharmacokinetics and metabolism in man显示文摘BROEKHUYSEN J STOCKIS A LINS R L 2000Int J Clin Pharmacol Ther2000,38,8:1
2Pharmacokinetics of nitazoxanide after single dose oral administration in 6 healthy volunteers显示文摘STOCKIS A DEROUBAIX X LINS R 1996Int J Clin Pharmacol Ther1996,34,8:1
3Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses显示文摘STOCKIS A ALLEMON A BRUYN DS 2002Int Clin Pharmacol Ther2002,40,5:1
4Food effect on the oral bioavailability of manidipine:single dose, randomized, crossover study in healthy male subjects显示文摘 Stockis A Poli G Acerbi D Lins R Jeanbaptiste B 1998Eur J Drug Metab Pharmacokinet1998,23,2:1
5Nitazoxanide pharmacokineties and tolerability in man using single ascending oral doses显示文摘STOCKIS A 2002International Journal of Glinical Pharmacology and Therapeutics2002,40,5:1
6Oral bioavailability ol CHF1194, an inclusion complex of piroxieam and beta-cyelodextrin, in healthy subjects under single dose and steady-state conditions显示文摘Deroubaix X Stockis A Allemon A M 1995Eur J Clin Pharmaeol1995,47,6:1
7Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice显示文摘Verrax J Stockis J Tison A 2006Biochem Pharmacol2006,72,6:1
8Dose-response population analysis of leve- tiracetam add-on treatment in refractory epileptic patients with partial onset seizures显示文摘Snoeck E Stockis A 2007Epilepsy Res2007,73,:1
9Nitazoxanide:pharmacokinetics and metabolism in man显示文摘BROEKHUYSEN J STOCKIS A LINS R L 2000Int J Clin Pharmacol Ther2000,38,8:1
10Bri- varacetam disposition in mild to severe hepatic impairment显示文摘STOCKIS A SARGENTINI-MAIER ML HORSMANS Y 2013J Clin Pharmacol2013,53,6:1
11Development and characterization of an in vitro alpha radiation exposure system显示文摘BEATON L A BURN T A STOCKI T J 2011Physics in Medicine and Biology2011,56,12:1
12Phys, Lett显示文摘Bonard J M Salvent J P Stocki T de Heer W A Forro' L Chatelain A Appl 1998731998,,:1
13Lack of pharmacokinetic in-teraction of LEV on carbamazepine,valproic acid, topiramate,and lamotrigine in children with epilepsy显示文摘Otoul C De Smedt H Stockis A 2007Epilepsia2007,48,11:1
14Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab) 显示文摘STOCKIS A DE BRUYN S DEROUBAIX X 2002Eur J Pharm Biopharm2002,53,1:1
15Clinical pharmacology of levetiracetam for the treatment of epilepsy显示文摘Stockis A Lu S Tonner F 2009Expert Rev Clin Pharmacol2009,2,4:1
16Lack of pharmaco?kinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy显示文摘OTOUL C DE SMEDT H STOCKIS A 2007Epilepsia2007,48,11:1
17Managing schizophrenia in general practice显示文摘Blashki G Keks N Stocky A 2004Australian Family Physician2004,33,:1
18The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men 显示文摘Rolan P Sargentini-Maier M L Pigeolet E Stockis A 2008Br J Clin Pharmacol2008,66,:1
19A moving mesh method with variable mesh relaxation time显示文摘Soheili A R Stockie J M 2008Applied Numerical Mathematics2008,58,3:1
20Lack of pharmacokinetic in- teraction o levetiracetam on carbamazepine, valproic acid, topiranmte, and lamotrigine in children with epilepsy 显示文摘Otoul C De Smedt H Stockis A 2007Epi- lepsia2007,48,11:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费